(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.
about
Theranostic Probes for Targeting Tumor Microenvironment: An Overview.Preclinical molecular imaging of tumor angiogenesis.Phage display and molecular imaging: expanding fields of vision in living subjects.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.Antibody phage display libraries: contributions to oncology.Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancerA comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancerThe ultimate radiochemical nightmare: upon radio-iodination of Botulinum neurotoxin A, the introduced iodine atom itself seems to be fatal for the bioactivity of this macromolecule.Recent trends in antibody-based oncologic imagingAdvances in immuno-positron emission tomography: antibodies for molecular imaging in oncologyPositron emission tomography tracers for imaging angiogenesis.The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity.New strategy for monitoring targeted therapy: molecular imaging.Antibody vectors for imaging.PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET.Clinical imaging of tumor angiogenesis.Alternative PET tracers in head and neck cancer. A review.Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.Multimodality Imaging in Tumor Angiogenesis: Present Status and PerspectivesPositive progress in immunoPET--not just a coincidence.Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions.Targeting Fibronectin for Cancer Imaging and Therapy.Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.Aligning physics and physiology: Engineering antibodies for radionuclide delivery.Emerging classes of armed antibody therapeutics against cancerImmunocytokinesThe antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model
P2860
Q30354655-26F24DA5-38AF-4BCC-90A0-3A62C38F551BQ30475818-AE8CB13C-A970-4200-AB9A-62D51059E957Q33849788-580EC34E-B315-4186-9B54-3117C3B58E6EQ34216877-348D4685-D9EC-413A-AC6E-52404E0CC7A5Q34323991-4FA2DD0F-DDFB-478D-81D4-4DEA26798BDEQ34334475-01BA68F2-891A-4A41-B08E-8259FCB2DA7AQ35027232-5D8EA0AC-2D11-48D5-9132-328CA5ACD95DQ35264634-90D87450-6D70-4DF0-BF6F-44985B071226Q35643425-7D6C7E80-6EC2-45A0-8848-65BDA349DCACQ36339722-D1CE5361-7993-4495-9D4B-F9DAD333FD11Q36777285-F8E3A5F6-0EFE-4DAB-A56D-B1A6A23BEDEEQ37185752-CEF10589-3A1D-49A9-A419-96318D30963EQ37225316-DFCEE397-156A-486E-9F19-1607BEDA0E89Q37720850-DF5840EE-25AE-4811-9882-C8862B92F4D7Q37978157-719568E3-176B-4961-BF13-649F40E6F55BQ38059503-211F0167-10FF-45F6-B91C-E09682618B9DQ38069937-831FFBF4-EA80-4072-815E-365B92878EA8Q38106992-DD4423B1-DE37-40C7-BAB2-BFF155936CB8Q41661199-1A6E184B-EF2E-46DF-A76D-2A2F0CB1CCA0Q42429164-722D5DE6-6DDA-42BA-8297-63915D39A228Q42489583-4723748D-F9A8-4FB5-BE0E-F583942B677CQ47226151-DF7DCF32-4880-425F-8D03-57968110A87CQ48136353-0680F309-D771-4807-A392-A0851F90F34DQ51740406-BF526A9B-61B6-49D7-B40A-53540901E223Q57911948-DFA87869-1C37-4395-B26F-352DC11EA78EQ57911975-63B8FC9A-9C41-4B40-B5C7-823B685B4528Q57912004-9C21457B-F5F8-46E7-AE1D-B38DC6748ED6
P2860
(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
(124)I-L19-SIP for immuno-PET ...... )I-L19-SIP radioimmunotherapy.
@en
type
label
(124)I-L19-SIP for immuno-PET ...... )I-L19-SIP radioimmunotherapy.
@en
prefLabel
(124)I-L19-SIP for immuno-PET ...... )I-L19-SIP radioimmunotherapy.
@en
P2093
P2860
P1476
(124)I-L19-SIP for immuno-PET ...... )I-L19-SIP radioimmunotherapy.
@en
P2093
Bernard M Tijink
C René Leemans
Gerard W M Visser
Guus A M S van Dongen
Lars R Perk
Ludger M Dinkelborg
Marianne Budde
Marijke Stigter-van Walsum
Reina W Kloet
P2860
P2888
P304
P356
10.1007/S00259-009-1096-Y
P50
P577
2009-03-04T00:00:00Z